REVIEW
Published on 31 May 2018
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
doi 10.3389/fimmu.2018.01169
- 9,571 views
- 62 citations